OBX02-011(Oncobix)

N/A

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameOBX02-011(Oncobix)
Drug Alias NameOBX02-011OBX-02-011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEGFR C797S inhibitorsEGFR L858R inhibitorsEGFR T790M inhibitors +[5] 
TargetsEpidermal growth factor receptor erbB1EGFR C797SEGFR L858R +[5] 
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncobix Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOncobix Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A